Imidazopyrazines as protein kinase inhibitors
US7511040B2 · kind B2 · utility
7Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2007 |
| Grant date | Mar 31, 2009 |
| Priority date | — |
| Expiry date | Nov 7, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or Aurora kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or Aurora kinases using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.